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Abstract
The costly nature of health sector responses to humanitarian crises and resource constraints
means that there is a need to identify methods for priority setting and long-term planning. One
method is economic evaluation. The aim of this systematic review is to examine the use of eco-
nomic evaluations in health-related humanitarian programmes in low- and middle-income coun-
tries. This review used peer-reviewed literature published between January 1980 and June 2018
extracted from four main electronic bibliographic databases. The eligibility criteria were full
economic evaluations (which compare the costs and outcomes of at least two interventions and
provide information on efficiency) of health-related services in humanitarian crises in low- and
middle-countries. The quality of eligible studies is appraised using the modified 36-question
Drummond checklist. From a total of 8127 total studies, 11 full economic evaluations were identi-
fied. All economic evaluations were cost-effectiveness analyses. Three of the 11 studies used a pro-
vider perspective, 2 studies used a healthcare system perspective, 3 studies used a societal per-
spective and 3 studies did not specify the perspective used. The lower quality studies failed to
provide 7information on the unit of costs and did not justify the time horizon of costs and discount
rates, or conduct a sensitivity analysis. There was limited geographic range of the studies, with 9 of
the 11 studies conducted in Africa. Recommendations include greater use of economic evaluation
methods and data to enhance the microeconomic understanding of health interventions in humani-
tarian settings to support greater efficiency and transparency and to strengthen capacity by recruit-
ing economists and providing training in economic methods to humanitarian agencies.
Keywords: Economic evaluation, humanitarian crisis, cost-effectiveness, disability-adjusted life years, public health interventions
Introduction
Humanitarian crises include complex emergencies such as armed
conflict, famines, major epidemic outbreaks and natural disasters
such as earthquakes. The health challenges faced by crisis-affected
populations, including refugees and internally displaced persons, in-
clude high mortality and morbidity rates due to communicable dis-
eases, malnutrition, non-communicable diseases (NCDs), poor
mental health and poor reproductive and sexual health. It was esti-
mated that 201 million individuals needed humanitarian protection
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and aid in 2017, with the vast majority living in low- and middle-
income countries (LMICs) (Global Humanitarian Assistance, 2018).
In the same year, a record of US$27.3 billion was spent on humani-
tarian assistance (compared with US$18.4 billion in 2013), with
much of it focused on conflicts in the Middle-East—most notably
Syria and Yemen (Global Humanitarian Assistance, 2018). With
increases in the number of people requiring humanitarian aid, rising
financial costs for providing humanitarian health services (particu-
larly NCDs), and resource constraints in aid availability, there is a
need to maximize the efficiency of the use of humanitarian aid and
ensure accountability and transparency and better planning and pri-
ority setting in its use (Spiegel et al., 2014; Spiegel, 2017).
The scarcity of resources in humanitarian settings becomes an eco-
nomic problem of how to allocate limited resources. One method to
help address this problem is through economic evaluations. An eco-
nomic evaluation is ‘the comparative analysis of alternative courses of
action in terms of both their costs and consequences’ (Drummond
et al., 2015). The main types of full economic evaluation include cost-
effectiveness (sometimes called cost-utility) and cost-benefit analyses.
The differences between approaches lie in details and sometimes are
more cosmetic than substantial. Broadly, cost-effectiveness/cost-utility
analysis involves comparison of costs and outcomes, with outcomes
expressed as natural units (e.g. cases averted) or, more commonly, in
generic measures of health outcome reflecting both mortality and
morbidity [e.g. quality-adjusted life years (QALYs) or disability-
adjusted life years (DALYs)]. In cost-benefit analyses, outcomes are
typically expressed in monetary units. Whatever the particular method
used, analyses can help to inform whether more effective but more
costly alternatives are worth the commitment of additional resources.
This requires assessing the benefits gained against what could other-
wise be gained with other uses of those resources (i.e. to opportunity
costs) (Drummond et al., 2015). A full description of the types of eco-
nomic evaluations is listed in Supplementary Data 1. Economic evalu-
ations can therefore support policy-makers and donors to better
understand which health interventions offer best value from the lim-
ited resources available, which can inform immediate spending deci-
sions, and support long-term budget planning decisions, as well as
efforts to generate additional resources for humanitarian crises. In
addition, there is a recognition of the value of integrating economic
evaluations into the current humanitarian landscape where there are
accountability and transparency deficits (Blanchet et al., 2017;
Spiegel, 2017; Roberts, 2018).
A number of systematic reviews have been conducted on evi-
dence on the effectiveness of health interventions in humanitarian
crises (Hall et al., 2011; Kimbrough et al., 2012; Tol et al., 2014;
Ramesh et al., 2015; Ruby et al., 2015; Smith et al., 2015; Blanchet
et al., 2017; Singh et al., 2018). However, to the best of our know-
ledge, there has been no systematic examination of the use of eco-
nomic evaluations of health-related interventions in humanitarian
settings. This systematic review aims to examine the use of economic
evaluations in health-related humanitarian programmes in LMICs.
The objectives were to: (1) analyse the use of economic evaluation
methods (cost-effectiveness, cost-utility and cost-benefit analyses) of
health interventions in humanitarian programmes and (2) assess the
quality of evidence using economic evaluation methods.
Materials and methods
This systematic review follows the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines
(Moher et al., 2009) and the Centre for Reviews and Dissemination
(CRD) guidance on systematic reviews of economic evaluations
(Centre for Reviews and Dissemination, University of York, 2009).
Search strategy
This review focused only on peer-reviewed literature published be-
tween 1 January 1980 and 30 June 2018 (as studies prior to 1980
were considered to be very few in number and of lower quality)
(Blanchet et al., 2017). This review used the following four main
electronic bibliographic databases, which is considered of great rele-
vance to the subject area: Medline, Embase, GlobalHealth and
EconLit. The search strategy consisted of search terms related to: (1)
humanitarian crises, (2) LMICs (as the vast majority of crisis-
affected populations lives in LMICs), (3) public health interventions
and (4) economic evaluations. The search terms for the first three
topics were obtained from the Humanitarian Health Evidence
Review (Blanchet et al., 2015). For the economic evaluation search
terms, the UK National Health Service (NHS) Economic Evaluation
Database (EED) search strategy was utilized with some modifica-
tions to incorporate characteristics from studies conducted in
LMICs. The NHS EED is a database containing abstracts of full eco-
nomic evaluations of health technologies (Centre for Reviews and
Dissemination, University of York, 2009). The NHS EED search
strategy contained search terms related to QALY, whereas DALYs
are more often used in LMIC settings; thus, search terms related to
DALYs were incorporated into the search strategy (Glanville et al.,
2009). The NHS EED strategy was chosen for its high sensitivity
and specificity (Glanville et al., 2009). A detailed list of all search
terms is presented in Supplementary Data 2.
Key Messages
• Economic evaluations are crucial in guiding humanitarian operational and policy decision-making, improving aid effi-
ciency and strengthening accountability.
• This review identified only 11 studies using economic evaluations of health interventions in humanitarian crises in low-
and middle-income countries. Few of these studies applied a societal perspective, most studies used aggregate pro-
grammatic costs data and the quality of the studies was mixed.
• Studies with lower quality scores focused on the effectiveness data and included limited costing data.
• There should be a greater focus on the use of economic evaluations of health interventions in humanitarian crises and
capacity strengthening on the collection and application of economic evaluation data among agencies and researchers
working in humanitarian crises.
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Inclusion and exclusion criteria
Table 1 lists the criteria used to select and exclude studies for this
review.
A humanitarian crisis is defined as ‘a serious disruption of the
functioning of a community or a society causing widespread human,
material, economic or environmental losses which exceed the ability
of the affected community or society to cope using its own resour-
ces, necessitating a request to national or international level for ex-
ternal assistance. The disaster situation may either be man-made or
a natural occurrence’ (Blanchet et al., 2015). Other key definitions
for public health interventions, and economic terms, are listed in
Supplementary Data 1. Only studies conducted in LMICs, as deter-
mined by the World Bank 2018 classification, were included because
the vast majority of civilians affected by humanitarian crises lives in
LMICs, and availability and use of resources differ significantly
from those in high-income countries (Blanchet et al., 2015; World
Bank Group, 2018). Studies related to post-conflict settings or with
armed combatants/military veterans were not included as these stud-
ies are not representatives of the unique environment or civilian pop-
ulations in crisis settings. In addition, for eligibility, studies needed
to have conducted an economic evaluation in a health-related hu-
manitarian programme.
Partial economic evaluations, such as costing studies, were
deemed to be ineligible for inclusion in the study. This decision was
made to fully understand and discuss the quality and quantity of full
economic evaluations that are conducted in health-related humani-
tarian programmes. Full economic evaluations provide a value for
money analysis by comparing the cost and outcomes of two or more
interventions, thus allowing an answer to questions related to effi-
ciency, whereas partial economic evaluations do not assess efficiency
(Napper and Newland, 2014).
Data screening and extraction
The data screening and extraction was performed in a five-stage pro-
cess by the authors LAM and NSS. The first stage consisted of
downloading and importing search results from the four databases
into a reference management software. In the second stage, dupli-
cates were removed. The third stage entailed screening the titles and
publication type for eligibility. Records were excluded if they were
not peer-reviewed journal articles or did not specify an economic
study on a health intervention in a humanitarian setting. The fourth
stage involved screening abstracts for eligibility. The fifth stage
included a full-text assessment for eligibility. The final stage assessed
whether the study was a full or partial economic evaluation. A full
economic evaluation compared both the costs and outcomes of two
or more interventions requiring a measurement and valuation of
both costs and outcomes (Napper and Newland, 2014). A partial
economic evaluation considered costs or outcomes but did not in-
volve a comparison between interventions nor did it relate costs to
benefits (Napper and Newland, 2014). The full economic evalua-
tions were determined to be eligible for data extraction and quality
assessment.
The data were extracted from the final selected studies into a
database in Microsoft Excel. The data extraction fields were broadly
classified into the following three main categories: study characteris-
tics, economic evaluation methodology and findings (Centre for
Reviews and Dissemination, University of York, 2009). The study
characteristics included: study authors, year, study country, title,
study objective/question, setting, population type, humanitarian cri-
sis type and public health intervention type. The economic evalu-
ation methodology included: economic evaluation type, perspective,
time horizon, discounting, comparator, analytical approach, effect-
iveness data, cost data, monetary benefit and utility valuation. The
findings were: key results, authors’ conclusions and quality
assessment.
Quality assessment
The following three quality assessment tools were reviewed to deter-
mine the best tool for assessing full economic evaluations: the
CHEC-list (Evers et al., 2005), the ‘Drummond’ 35-point checklist
(Drummond and Jefferson, 1996) and the modified ‘Drummond’
36-point checklist (Centre for Reviews and Dissemination,
University of York, 2009). The CHEC-list was deemed to be unsuit-
able for this review as it primarily focuses on clinical trials and does
not include questions related to productivity changes, an important
factor for humanitarian settings. Although the Drummond 35-point
Table 1 Inclusion and exclusion criteria
Category Included Excluded
Population of interest Populations that are affected by humanitarian crises, armed
conflict, natural and man-made disasters and early recov-
ery in low- and middle-income countries. The low- and
middle-income countries were determined using the
2018 World Bank classification
Studies that focus on humanitarian crises in high-income
countries
Studies centred on asylum seekers or refugees in high-in-
come countries
Studies related to military combatants and military veterans
Intervention Any health-related intervention (i.e. communicable disease,
NCDs, nutrition, sexual and reproductive health, mental
health and psychosocial support, injury and rehabilita-
tion, water, sanitation and hygiene)
Studies that do not specify health interventions
Types of studies Full economic evaluations such as cost-effectiveness, cost-
utility, cost-benefit and cost minimization. The study de-
sign could be a randomized controlled trial or modelling
studies
The following studies were excluded: partial economic
evaluations, review papers, studies examining prepared-
ness and resiliency not linked to an intervention and
studies not linked to any health outcomes in a humani-
tarian context
Outcomes and outputs
of interest
Primary outcomes (e.g. incremental cost-effectiveness ratio)
Secondary outcomes (e.g. cost per case averted)
Primary outputs (e.g. cost)
Costing-only studies
Data type Studies must try to relate cost to outcome data Costing-only studies
Date of publication 1 January 1980 to 30 June 2018
Publication language English Other languages
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checklist was widely used, the modified 36-point Drummond check-
list was chosen as the quality assessment tool because it contained
an additional item assessing the generalizability of results, making it
the most comprehensive checklist for this review. The remaining 35
questions were the same questions found on the original Drummond
checklist.
A quality scoring system was developed based on the 36-item
checklist and grouped into the following three broad categories:
study design, data collection and analysis and interpretation of
results. Each question under each category was given equal weight-
age. The study design contained 7 questions, the data collection
included 14 questions and the analysis and interpretation of results
had 15 questions. A full list of the quality assessment questions are
presented in Supplementary Data 3.
Data analysis
Descriptive thematic analysis was used, guided by the
study objectives and extraction sheet criteria (e.g. study charac-
teristics, evaluation methods, analytical perspective and ap-
proach). This was conducted independently by two authors, and
any discrepancies were resolved through discussions with the se-
nior author. A meta-analysis was deemed inappropriate as the
studies reporting a range of interventions and outcomes were
not consistent for a statistical procedure. In addition, a meta-
analysis did not meet the study objectives. Instead, a narrative
synthesis approach was used to analyse the data (Petticrew et al.,
2013).
Results
Identification and selection of studies
A total of 10 746 studies were extracted from four peer-
reviewed databases (Medline 1997; Embase 3944; GlobalHealth
1594; EconLit 3211). Figure 1 displays the PRISMA flow
diagram.
After removing duplicates, a total of 8127 studies were screened
by their titles. After the screening of title and publication type, a
total of 210 articles were screened for their abstracts. This stage
resulted in 154 articles being excluded because studies were con-
ducted in a high-income country, not in a humanitarian setting,
were published in a different language or did not include a health
intervention. The remaining 56 studies went through a full-text as-
sessment where 30 articles were excluded for the following reasons:
the study was not written in English, focused on refugees in a high-
Records identified through 
database searching 
(n =10,746) 
Records after duplicates 
removed 
(n =8,127) 
Records screened 
(n =210) 
Records excluded 
(n = 154) 
Full-text articles 
assessed for eligibility 
(n = 56) 
Excluded 
(n = 30) 
Full and Partial Economic 
Evaluations Identified  
(n = 26) 
Full Economic 
Evaluations Identified 
(n = 11) 
Costing 
Studies 
(n = 15) 
-Not in English (4) 
-Refugees in HICs (7) 
-No health intervention (13) 
-Not a humanitarian setting (6) 
Figure 1. PRISMA flow diagram
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income setting, did not have an intervention or did not meet criteria
for a humanitarian setting. The remaining 26 studies included 11
economic evaluations that met inclusion criteria and 15 costing
studies that were excluded. Although partial economic evaluations
such as costing studies did not meet inclusion criteria, the costing-
only studies are listed in Supplementary Data 4 as they might be of
interest to researchers.
Study characteristics
Over a span of almost 20 years, 11 economic evaluations meeting
eligibility criteria were published and the study characteristics are
summarized in Table 2.
The oldest study was published in 1998, whereas the latest study
was published in 2017. Of the 11 studies, 9 studies were published
in the last decade. Of the 11 studies, 9 studies were conducted in
African countries, 1 study was conducted in Haiti and the remaining
1 study was conducted in Pakistan. Most studies focused on
conflict-affected settings, two studies focused on a natural disaster
and one study focused on a disease outbreak setting. Seven studies
focused on communicable diseases: one study on rehydration ther-
apy for cholera, one study on an intervention for visceral
leishmaniasis, one study on comparing four cholera control pro-
grammes, one study on adding the rotavirus vaccine, one study on
Haemophilus influenzae type B conjugate (Hib) vaccine and
pneumococcal conjugate vaccine (PCV) for acute respiratory infec-
tions, one study on indoor residual sprayings for malaria and one
study on the Hib vaccine and PCV vaccine for acute respiratory
infections. There were one study on community-based therapeutic
care for nutrition, one study on short orthopaedic missions for in-
jury and rehabilitation services, one study on a mental health behav-
ioural intervention and one study on obstetric care. Of the 11
studies, 8 studies noted that the compared health intervention was
cost-effective, one study noted that the intervention was not cost-ef-
fective, and the conclusions from the remaining two studies were un-
clear. The key findings from the 11 economic evaluation studies are
summarized in Supplementary Data 5.
All of the identified economic evaluations used cost-effectiveness
analyses, and they used various perspectives of cost-effectiveness
analysis (Table 2). Of the 11 studies, 3 studies used a healthcare pro-
vider prospective, 2 studies adopted a healthcare system perspective,
3 studies used a societal perspective and 3 studies did not specify the
perspective used, which is considered poor practice in economic
Table 2 Study characteristics of eligible economic evaluation studies (N¼ 11)
Study authors
(year)
Study
country
Population
type
Humanitarian
crisis type
Type of public
health
intervention
Type of economic
evaluation
Perspective Analytical
approach
Measure of
outcome
Naficy et al.
(1998)
Malawi Refugee Conflict Cholera treatment
and vaccination
Cost-effectiveness Provider Decision tree Cost per cholera
case prevented
Cost per cholera
death averted
Griekspoor
et al. (1999)
Sudan General
population
Conflict Treatment of vis-
ceral
leishmaniasis
Cost-effectiveness Not specified Not specified Cost per DALY
averted
Gosselin et al.
(2011)
Haiti General
population
Natural
disaster
Orthopaedic
trauma
Cost-effectiveness Provider Not specified Cost per DALY
averted
Tekeste et al.
(2012)
Ethiopia General
population
Natural
disaster
Treatment for
SAM
Cost-effectiveness Societal Not specified Cost per cured
case
Deboutte et al.
(2013)
Democratic
Republic
of Congo
Pregnant
women
Conflict EmOC Cost-effectiveness Not specified Not specified Cost per HALE
gained
Sardar et al.
(2013)
Zimbabwe General
population
Outbreak Cholera vaccin-
ation, treat-
ment, sanita-
tion and health
promotion
Cost-effectiveness Not specified Mathematical
modelling
Cost per case
averted
Gargano et al.
(2015)
Somalia Internally dis-
placed
population
Conflict Rotavirus immun-
ization for diar-
rheal disease
Cost-effectiveness Healthcare
system
Decision tree Cost per DALY
averted
Gargano et al.
(2015)
Somalia Refugee Conflict Vaccination for
ARI
(pneumonia)
Cost-effectiveness Healthcare
system
Decision tree Cost per DALYs
averted
McBain et al.
(2016)
Sierra
Leone
General
population
Conflict Mental health—
Youth
Readiness
Intervention
Cost-effectiveness Societal Markov
modelling
Cost per QALY
gained
Gargano et al.
(2017)
South
Sudan
Refugee Conflict Vaccination for
ARI
(pneumonia)
Cost-effectiveness Provider Decision tree Cost per DALYs
averted
Howard et al.
(2017)
Pakistan Refugee Conflict Targeted IRS Cost-effectiveness Societal Not specified Cost per DALYs
averted
SAM, severe acute malnutrition; EmOC, Emergency Obstetric Care; HALE, health-adjusted life expectancy; ARI, acute respiratory infection; IRS, indoor re-
sidual spraying.
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evaluation. The costs of health care are grouped into direct medical
(e.g. medicines and health service provider costs), direct non-
medical (e.g. transport costs to patient and health facility), indirect
medical (e.g. costs of health care not directly related to interventions
under evaluation, such as health workers in a health facility but not
directly involved in the intervention) and indirect non-medical costs
(e.g. management and supervisory costs), patient costs (e.g. out-of-
pocket costs) and productivity costs (e.g. loss of income due to dis-
ability and premature death). The issue of which costs to include in
an economic evaluation depends on the perspective of the analysis.
Three studies used a provider perspective and accounted for the dir-
ect and indirect medical costs incurred by the humanitarian agency
providing the services. The health system perspective includes direct
and indirect costs related to medical services and direct non-medical
costs within the scope of the health system (e.g. medicine transport
costs and subsequent use of health care at other facilities), and two
studies that used a healthcare system perspective compared the cost-
effectiveness of a supplemental humanitarian programme with that
of a national health programme. The societal perspective is the most
holistic approach and includes all direct and indirect medical and
non-medical provider and health system costs irrespective of who
incurs the costs (e.g. patient transport costs to facilities and product-
ivity loss such as lost earning by the patient), and three studies using
a societal perspective reported costs to the healthcare system and
also productivity costs to the society as a result of the health
condition.
The analytical approach also varied among the 11 studies
(Table 2). Four studies used decision tree analysis, one study used a
Markov model, one study used a mathematical model and five stud-
ies did not specify an analytical approach. There were also differen-
ces in the way the outcome measures were reported. Seven studies
reported outcomes as cost per DALY averted or health-adjusted life
expectancy or QALY gained, whereas the remaining studies
reported outcomes as cost per case averted, or cost per death
averted.
Quality assessment findings
The quality of studies assessed on the study design, data collection
and analysis and interpretation of results shows that most studies
reported comprehensively on the study design techniques but lacked
quality in data collection and interpretation of the results (Table 3).
For study design, 8 of the 11 studies were sufficiently well
designed, scoring 5/7 for the study design criteria. Only one study
scored a full 7/7, and three studies scored 2/7 or 4/7 on the quality
scoring metrics. The low-quality studies lacked the justification
required for choosing a cost-effectiveness analysis or did not state
the importance and rationale for the interventions chosen.
The scoring on the quality of data collection recorded 3 of the 11
studies as high quality. These three studies scored 12/14 or higher
on the data collection methods and were able to justify the sources
of effectiveness and cost data as well as clearly state the assumptions
and methodology required to document the economic costs. Six
studies that exhibited poor quality scored between 4/14 and 8/14,
tended to exclude information on the source of effectiveness, the
valuation of health states, price adjustment and currency conversion
and did not report resources separately from unit costs. These six
studies lacked details about how data were synthesized and the rea-
son behind the analytical model used. Two studies were of moderate
quality, scoring 10/14 or 11/14 on the data collection techniques.
The quality assessment on the analysis and interpretation of
results evaluated the studies on the choice of parameters such as dis-
count rates, as well as the sensitivity analysis and results communi-
cated in the studies. Of the 11 studies, 3 studies exhibited high
quality by meeting all 15/15 criteria, 4 studies exhibited medium
quality and 4 studies exhibited low quality. The studies with low
quality failed at noting and justifying a time horizon of costs and
discount rates and exhibited a lack of reporting on sensitivity analy-
ses. Only 7 of the 11 studies addressed the generalizability of results
in their discussion. Studies that scored good quality in the data col-
lection section also performed well in the analysis and
interpretation.
Discussion
Study findings
To the best of our knowledge, this review is the first of its kind to
systematically examine the use of economic evaluation studies of
health interventions in humanitarian settings. The key finding of this
review is that there is limited evidence of full economic evaluations
of health interventions in humanitarian programmes. This suggests
that opportunities are being missed to help guide operational and
policy decision-making and to improve the efficiency and account-
ability of humanitarian health programming.
Overall, 11 studies represent good practices in identifying and
using outcomes data, but they contain some limitations in the appli-
cation of economic data. The study design assessment suggested that
most studies justified the choice of economic evaluation and inter-
ventions for the study design. The variance in quality between stud-
ies primarily occurred in the data collection and analysis techniques.
The quality of studies is important as these studies provide effective-
ness and cost data that can be utilized for resource allocation deci-
sions and thus for budgetary considerations for humanitarian
programmes.
The perspective for the evaluations ranged from provider to soci-
etal. The studies pursuing a provider perspective tended to use data
from non-governmental organizations, whereas the healthcare sys-
tem perspective was used when the intervention compared a nation-
al programme with a supplemental programme. Only three studies
utilized a societal perspective. Three studies did not specify the per-
spective, and it was assumed that these studies were likely from a
provider perspective based on the use of administrative cost data.
According to the World Health Organization (WHO) CHOICE
Table 3 Quality assessment scores
Studies Study
design
(n¼ 7)
Data
collection
(n¼ 14)
Analysis and
interpretation
of results
(n¼ 15)
Naficy et al. (1998) 6 6 12
Griekspoor et al. (1999) 5 8 11
Gosselin et al. (2011) 2 4 2
Tekeste et al. (2012) 5 5 4
Deboutte et al. (2013) 5 6 9
Sardar et al. (2013) 2 5 3
Gargano et al. (2015) 6 11 15
Gargano et al. (2015) 6 14 15
McBain et al. (2016) 6 14 12
Gargano et al. (2017) 4 10 10
Howard et al. (2017) 7 12 15
n ¼ the total number of questions under each section.
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guidelines on general cost-effectiveness analysis, a wider societal
perspective is recommended to demonstrate all costs regardless of
who pays (World Health Organization, 2003). The studies may not
have taken a societal perspective because of the availability or diffi-
culty of collecting cost data. This could be improved by planning a
costing structure at the start of the study. Although the study per-
spective may not be societal, it is still important to make an inven-
tory list of productivity costs of crisis-affected populations. This will
be helpful for conducting sensitivity analysis to determine the
strength of the parameters and assumptions. The information is also
important to understand costs incurred by both providers and
beneficiaries.
The higher quality studies were able to clearly state and justify
the necessary components such as the time horizon, the analytical
approach, discount rate and parameters. The studies also converted
prices to appropriate currencies, accounted for inflation in the cost
analysis, and presented the major outcomes in both aggregated and
disaggregated forms. The weaker studies lacked a clear justification
for conducting an economic study. These studies seemed to focus
primarily on the effectiveness data and contained little information
on the source of the cost data. This possibly indicates that the cost
component was added later rather than at the inception of the
project.
The weaker studies also used financial costs without converting
them into economic costs, which include opportunity cost. In hu-
manitarian setting, many programmatic interventions are supported
by donations, which do not have any immediate financial conse-
quence but there is an opportunity for costs of benefits forgone from
the next best alternative use of those resources. The costs tended to
be aggregated rather than evaluated on a unit basis. The studies
mostly focused on shorter time horizons due to the humanitarian
settings; although a proportion of fixed costs should have been
apportioned to interventions, it often was not clear if and how this
was done, and most studies included only variable costs instead. The
reason for using variable costs might be because it was easier to esti-
mate based on the quantity of inputs and outputs reported for the
programme. Many studies also did not specify the discount rates for
both costs and outcomes. One study reported a 10% discount rate,
but this may be overestimated based on the inflation data from the
conflict-affected country.
There also seemed to be problems in how outcomes were
reported. The studies appeared to conduct cost-effectiveness by
comparing the ratio of effectiveness measures over the total costs,
rather than an incremental analysis (a ratio of the difference in costs
and effects of the two alternatives). The reported outcomes tended
to be in terms of cost per DALY averted, consistent with the WHO
CHOICE guidelines that recommend the use of DALYs as an out-
come measure (World Health Organization, 2003).
Another key aspect of economic evaluation is conducting a sensi-
tivity analysis to test the robustness of the parameters and assump-
tions of the analytical model. The sensitivity analysis informs the
readers whether the results will still be within a sizeable range if the
parameters were shifted. Many of the studies did not report on a
sensitivity analysis. Although some studies only included a one-way
analysis, a robust approach for high-quality studies would include a
probabilistic analysis.
Policy implications
There are clearly numerous challenges for incorporating economics
in humanitarian programmes. First, substantial security and logistic-
al challenges arise in the complex contexts of humanitarian crises,
including population mobility and lack of control groups
Humanitarian interventions must be prompt and so may allow little
time for preparation for economic evaluations. There may also be
capacity challenges, with humanitarian agencies lacking technical
capacity to conduct such studies, including not having the robust in-
formation systems required to support economic evaluations (and
more effective decision-making more broadly). There are also ethical
constraints. For example, if the evaluation implies withholding
assistance.
Despite the logistical, capacity and ethical challenges, many
studies on the effectiveness of health interventions, including
randomized controlled trial designs, have been conducted in such
settings (Blanchet et al., 2017). Therefore, these challenges can be
overcome in some circumstances, particularly more stable contexts
such as longer-term refugee situations. Depending on the economic
perspective used, data on costs can be relatively easily incorporated
into effectiveness studies (although the economic costs, including
opportunity costs, would need to be calculated). Economic evalua-
tions reporting cost-effectiveness can then allow decision-makers to
rank alternatives and provide a common measure to assess budget-
ary impact and identify programmes to scale up. The benefits could
be substantial through improved efficiency, value for money, health
benefits, equity and transparency and accountability. Indeed,
Carbonnier (2016) noted the untapped potential for humanitarian
economics.
There are a number of potential explanations for this gap in the
use of economic evaluation studies. First, there may be limited
awareness of the benefits of economic evaluation among donors,
governments and agencies working on humanitarian response. This
may be coupled with a lack of expertise on health economics in hu-
manitarian responses and research. Second, there may also be mis-
understandings around the role of economic evaluation, with a
misconception that it may lead to withholding humanitarian assist-
ance to particular vulnerable groups. This is not the case, and in-
stead economic evaluations can help maximize benefits and improve
equity. Third, there may also be a lack of political will, with donors
and implementing agencies wary of conducting (cost)-effectiveness
studies in case the outcomes are unfavourable (and instead prefer-
ring to focus on inputs and outputs). This calls for better transpar-
ency, accountability and governance in humanitarian organizations
and the sector more broadly, including collecting and reporting data
on economic evaluations of their activities (Blanchet et al., 2017;
Roberts, 2018).
Clearly, not every programme’s cost-effectiveness should be eval-
uated; rather, cost-effectiveness should be established for key new
interventions with limited or no existing cost-effectiveness data.
There are also data from economic evaluations from interventions in
more stable settings that could be applied or adjusted to humanitar-
ian settings. Similarly, the timing of implementing cost-effectiveness
studies is important for determining the use of economic evaluation
methods. For example, although cost-effectiveness evidence for key
sexual and reproductive health interventions is urgently needed
(Singh et al., 2018), there is an argument for not evaluating the cost-
effectiveness of implementing each sexual and reproductive health
intervention at the onset of a crisis when costs will likely be higher
than in a protracted setting.
Opportunities for economic evaluation
The inherent contextual constraints of conducting economic evalua-
tions in humanitarian settings are fully recognized, but there is still
an opportunity to conduct the (cost)-effectiveness studies to support
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policy-makers and funding institutions in decision-making (Ager
et al., 2014). When effectiveness studies are being designed, it is im-
portant to also think about the cost component. The costing struc-
ture or economic evaluation can be integrated in the studies at the
inception of the project rather than as an afterthought. Ensuring
that accurate costing data are collected also requires sufficiently ro-
bust information systems. Study designs such as quasi-experimental
designs, interrupted time series and/or matching can be used to help
obtain the effectiveness data required for economic evaluations in
the challenging contexts of humanitarian crises. Econometric meth-
ods can then be used to support the analysis. This information will
also prove valuable in gaining new insights into the different types
of costs associated with the intervention, including the productivity
and opportunity costs, which can also help to inform future inter-
ventions. The perspective of the economic evaluation is crucial to
determine and report, and where feasible and appropriate, a societal
perspective should ideally be applied, to ensure that the full range of
costs and benefits, particularly related to the recipients, is included.
Government, donors and humanitarian agencies and organiza-
tions need to start addressing the gap in using economic evaluation
methods by better utilizing economists to understand and report on
the economic challenges. They can also strengthen the capacity of
policy-making staff to better use economic evaluation methods.
Universities should strengthen teaching on the particular challenges
of conducting economic evaluations in humanitarian settings.
Investment is also required by donors and humanitarian agencies in
improved information systems to allow for the better collection of
more accurate, transparent, comparable and timely data for eco-
nomic evaluation.
Study limitations
This review included only English-language studies, although
articles in other languages may be relevant. In addition, this review
only considered peer-reviewed articles and the inclusion of grey lit-
erature, expert interviews or reviews of references may have resulted
in a greater number of eligible studies. Disease outbreak and epi-
demic search terms were not included in the search strategy as this
would have significantly reduced the specificity of the search. Any
epidemics or outbreaks of major importance are typically labelled as
humanitarian emergencies by authorities and researchers/publica-
tions. This approach was based on expert consultation for other sys-
tematic reviews we have previously conducted on humanitarian
crises (Blanchet et al., 2015). The quality scores were calculated by
giving equal weightage for each question, which may skew the qual-
ity scores as it could be argued that some questions should have
received more weight than others. This method for quality scores
was chosen because the use of other published quality scores was
not recommended by the CRD guidance (Centre for Reviews and
Dissemination, University of York, 2009). This review only focused
on full economic evaluations, while briefly highlighting the partial
economic evaluations, thus limiting the total number of studies that
could be identified for quality assessment. It is important to note
that both full and partial economic evaluations are important in hu-
manitarian settings, and further research could examine the quality
of costing studies in humanitarian settings. The geographical loca-
tion of the studies reported in this systematic review is mostly
located in Africa. Thus, there is limited generalizability from indi-
vidual study findings to other continents. This is particularly so
given that humanitarian crises are very context specific so even more
challenging to generalize than for other economic evaluations
conducted in more stable settings (for which, even then, generaliz-
ability can be difficult).
Conclusion
Economic evaluations provide information on efficiency and, thus,
are a good tool to use when assessing value for money in resource
constraint settings. This review identified only 11 economic evalua-
tions of public health interventions in humanitarian settings,
LMICs, with most in sub-Saharan Africa. Areas for improvement in
future economic evaluations were identified, including the sourcing
of cost data, productivity changes, sensitivity analysis and valuation
of health states and costs to improve the quality of economic studies.
Furthermore, utilizing quasi-experimental techniques will aid in
enhancing micro- and macroeconomic understanding of health
interventions in humanitarian settings. The greater use of, and cap-
acity in, economic evaluation methods in humanitarian crises would
support decision-making, improve efficiency and value for money,
prioritize and scale up health programmes and strengthen the trans-
parency and accountability of humanitarian aid.
Supplementary data
Supplementary data are available at Health Policy and Planning online.
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